Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006994
Filing Date
2025-05-08
Accepted
2025-05-08 16:30:27
Documents
57
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tela-20250331x10q.htm   iXBRL 10-Q 1095948
2 EX-31.1 tela-20250331xex31d1.htm EX-31.1 12798
3 EX-31.2 tela-20250331xex31d2.htm EX-31.2 12787
4 EX-32.1 tela-20250331xex32d1.htm EX-32.1 7137
5 EX-32.2 tela-20250331xex32d2.htm EX-32.2 7347
  Complete submission text file 0001558370-25-006994.txt   5542224

Data Files

Seq Description Document Type Size
6 EX-101.SCH tela-20250331.xsd EX-101.SCH 36718
7 EX-101.CAL tela-20250331_cal.xml EX-101.CAL 50849
8 EX-101.DEF tela-20250331_def.xml EX-101.DEF 146533
9 EX-101.LAB tela-20250331_lab.xml EX-101.LAB 383577
10 EX-101.PRE tela-20250331_pre.xml EX-101.PRE 269254
60 EXTRACTED XBRL INSTANCE DOCUMENT tela-20250331x10q_htm.xml XML 896150
Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Filer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39130 | Film No.: 25926778
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)